![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista de Categorias
AlcoolismoAlzheimer E ParkinsonAnalgésicosAnti-InflamatóriosAnti-helmínticosAnti-viraisAntialérgicosAntibióticosAnticoncepcionaisAnticonvulsivantesAntidepressivosAntifúngicosArtriteAsmaCancroCirúrgiaColesterolCuidados Da PeleCuidados Para Los OjosDiabetesDisfunção EréctilDiuréticosDoenças CardiovascularesEnxaquecasH I VHipertensão ArterialObesidadeOsteoporosePerturbações MentaisPerturbações NeurológicasRelaxantes MuscularesSaúde FemininaSaúde MasculinaTrato GastrointestinalTrato RespiratórioTrato Urinário 12 May 2012 08:52:15
Strontium: A better way to build bonesStrontium: A better way to build bones Tulsa World I wish more physicians would suggest over-the-counter strontium supplements before prescribing bone-building "bisphosphonate" drugs like Actonel, Boniva and Fosamax or even Evista or Forteo. A 2004 study in New England Journal of Medicine concluded ...
11 May 2012 21:06:12
FDA Report Suggests Women Reassess Bone Drug Use Due To Serious Adverse Events RedOrbit FDA Report Suggests Women Reassess Bone Drug Use Due To Serious Adverse Events RedOrbit The FDA said doctors need to reassess which women are likely to benefit from bisphosphonates such as Fosamax , Actonel and Reclast, given the lack of concrete evidence that taking them over long periods really helps them and the possibility that they ... Women warned about long-term use of bone drugs11 May 2012 04:07:36
FDA Analysis Cautions Against Long Term Fosamax Use Due to Bisphosphonate ... ABC News FDA Analysis Cautions Against Long Term Fosamax Use Due to Bisphosphonate ... San Francisco Chronicle (press release) Bernstein Liebhard LLP reports that new FDA analysis cautions against the long term use of Fosamax in light of its limited benefits and the possibility of bisphosphonate complications. New York, New York (PRWEB) May 10, 2012 Bernstein Liebhard LLP ... Why Were Risky, Ineffectual Bone Drugs Approved, Some Are Asking Does Fosamax Cause Esophageal Cancer? Concerns raised over long-term use of bone drugs -10 May 2012 15:07:37
AM Vitals: Pfizer Parts With LipitorAM Vitals: Pfizer Parts With Lipitor Wall Street Journal (blog) New Cautions About Long-Term Use of Bone Drugs (New York Times): An FDA-led review of bone-strengthening drugs such as Merck's Fosamax published in online in the New England Journal of Medicine concluded: Take with caution.
10 May 2012 12:18:40
Long-term use of osteoporosis medication may reduce bone fracture risk for ...Long-term use of osteoporosis medication may reduce bone fracture risk for ... Medical Xpress The study was funded by Merck, the maker of Fosamax , a commercial version of alendronate. Osteoporosis is responsible for 1.5 million fractures in the United States a year at a cost of $14 billion annually. As many as half of all women and a quarter of ...
10 May 2012 00:33:03
New Cautions About Long-Term Use of Bone Drugs New York Times (blog) New Cautions About Long-Term Use of Bone Drugs New York Times (blog) An X-ray shows a fracture in the femur of a woman who used Fosamax for seven years. In an unusual move that may prompt millions of women to rethink their use of popular bone-building drugs, the Food and Drug Administration published an analysis that ... Bone Drugs May Not Help Women Long Term, FDA Review Says Long Term Use of Bone-Strengthening Drugs Could Lead to Weaker Bones FDA Still Cautious About Bone Drugs - -27 Apr 2012 19:37:15
On the Call: Merck CEO Kenneth C. FrazierOn the Call: Merck CEO Kenneth C. Frazier BusinessWeek Merck pioneered osteoporosis drugs -- taken to prevent sometimes crippling fractures in the spine, hip and other joints -- with its blockbuster Fosamax . Fosamax and several newer, rival drugs are part of the class called bisphosphonates, which inhibit ... Dental Implants Affected by Osteoporosis Drugs
24 Apr 2012 16:30:35
Rottenstein Law Group Disheartened by Merck's Claim of Fifth Fosamax Court VictoryRottenstein Law Group Disheartened by Merck's Claim of Fifth Fosamax Court Victory Albany Times Union The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax , is disheartened to learn that manufacturer Merck is claiming victory in a fifth lawsuit. In a press release dated April 18, ...
|
|
Choose Your language:
Pesquisa no site:
Testemunhos
Olá, obrigado,
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mais vendidos|Política|Questões Mais Frequentes|Testemunhos|Contacte-nos|Sitemap |
|
|
|
|
| |